顧客増加は結果です。経営パートナーが利用率を下げずに繰り返せるルートを選ぶことです。 会計事務所にとってこれが難しいのは構造的です。コンプライアンス料金の圧縮と、法定業務のアウトプットを減らさずにアドバイザリーへ時間を移せない点にあります。したがって信頼できる答えは82%の実現率と71%の請求可能利用率を同じ視点で保つ必要があります。これが内部分析が止まる理由です。2つは異なるシステムに存在するためです。
顧客増加は結果です。経営パートナーが利用率を下げずに繰り返せるルートを選ぶことです。 会計事務所にとってこれが難しいのは構造的です。コンプライアンス料金の圧縮と、法定業務のアウトプットを減らさずにアドバイザリーへ時間を移せない点にあります。したがって信頼できる答えは82%の実現率と71%の請求可能利用率を同じ視点で保つ必要があります。これが内部分析が止まる理由です。2つは異なるシステムに存在するためです。
ほぼ全ての事務所がコンプライアンスまたはアドバイザリーの受注方法をいくつか挙げられますが、そのうちどれが実現率を82%以上に、請求可能利用率を71%以上に引き上げるかを言える事務所は少ないです。これが実際の制約です。戦術の不足ではなく、法定業務のアウトプットを減らさずにどれを増やすかの根拠がないことです。
生産的な枠組みはルート経済です。各ルートについて、1件の顧客獲得に請求可能時間がどれだけかかり、粗利益で回収するまでどれだけかかり、規模を拡大しても実現率が下がらずに繰り返せるかを確認します。
ほとんどのルートはこの3つ目のテストに通りません。小規模では経営パートナーの人脈や注意で機能しますが、規模を拡大すると法定業務のアウトプットを減らさずに続けられなくなり、静かに止まります。
この3つが揃うと特徴的です。1つだけでは別のことを示すことが多いです。
✓ 成長は経営パートナーの関係性に依存しており、コンプライアンス顧客の91%が継続しています
✓ 実現率または利用率は43.2mの売上と210 FTEスタッフ全体での集計値しか把握できていません
✓ アドバイザリーの新規ルートはどれも少しずつ試されていますが、34%の勝率でどれが有効かを正しく検証できていません
通常、事態を悪化させる対応です。 複数のルートを小規模で同時に走らせることです。どのルートも決定的な結果が出ず、請求可能時間が分散して減ります。
It is for you if you run or finance an accounting firm and growth depends on one person's relationships. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 会計事務所. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Pennmark Advisory, a sample company profile used for testing rather than a customer — 43.2m total revenue with 210 fte staff.
Excerpt from a real Percision run · Customer Value Architecture · sample company profile
The move. Convert 15,000 compliance hours into $1.9M incremental EBITDA by embedding advisory inside existing client relationships.
| Investment required | $0.8M-$1.2M for 6 FTE conversion specialists (salary + training); funded entirely from existing $7.8M EBITDA within 24-month payback constraint |
| Expected return | Base case: $1.9M incremental EBITDA on $1.0M investment = 1.9× return within 24 months; Low case: $1.4M EBITDA (26% lower pipeline conversion); High case: $2.4M EBITDA (26% higher win rate) |
| Revenue, year 1 | $0.6M incremental advisory revenue (partial year, 6 specialists hired Q2 2027) |
| Revenue, year 2 | $1.9M incremental EBITDA (full-year run rate) |
| Revenue, year 3 | $2.8M incremental EBITDA (additional 4 specialists funded by Year 2 cash flow) |
| Exit criteria | Strategy should be reversed if, within 18 months, (a) advisory win rate falls below 25% for two consecutive quarters, OR (b) compliance retention drops below 88%, OR (c) incremental EBITDA from conversion specialists fails to reach $800K annual run-rate by Month 18 |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Go-to-Market & Commercial Strategy, one of 29 engagements the platform runs. For 会計事務所 it works through 82% realisation rate, 71% billable utilisation, 34% advisory win rate and 91% compliance client retention, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 完全なレポートはこちらをご覧ください if you would rather see the depth first.
買い手がすでにいて、獲得コストを回収できる期間で返済できるものです。これは事業ごとに異なり、一般論はほとんど役に立ちません。
1つが機能してから2つ目です。必要な予算の4分の1で4つを同時に走らせると、4つとも結論が出ず、何も機能しないという思い込みが生まれます。
販売サイクルに回収期間を加えた期間です。十分な件数でノイズと区別できる結果が必要です。あらかじめその数値を決めておくことで、説得力の強い人の意見で判断が左右されるのを防げます。
Materially, yes. Compliance fee compression and inability to shift hours to advisory without reducing statutory output — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 82% realisation rate, 71% billable utilisation, 34% advisory win rate, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 82% realisation rate and 71% billable utilisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית